According to the visually defined cutoff that splits the NSCLC cases into high/positive versus low/negative expression (signal vs. background noise), tumor LAIR-1 positivity was detected in approximately 18% of patients with NSCLC. This evidence concerns the gene LAIR1 and non-small cell lung carcinoma.